ArticleScientific reports2025
Biochemical and biophysical characterization of Plasmodium falciparum glucose regulated protein 170.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The main malaria parasite, Plasmodium falciparum expresses 6 Hsp70 proteins. Among them, two are Hsp110 homologues localised in the cytosol and endoplasmic reticulum. The cytosolic Hsp110 (PfHsp70-z) has been fairly studied but the ER, PfGrp170 (PfHsp70-y) has not been well characterised. PfGrp170 is essential for parasite survival and is thought to be important for protein folding during exportation of parasite proteins to the host cell cytosol. Therefore, this study optimised the conditions for its overexpression in an E. coli system and investigated the structure-functional features of Grp170 protein. The recombinant full-length version of PfGrp170 was successfully produced under native conditions. The secondary structure analysis showed a predominantly α-helical structural features which exhibit moderate thermal stability with a Tm above 55 °C. The presence of nucleotides, such as ATP perturbed the structural stability of PfGrp170 making it more sensitive to heat stress and proteolytic cleavage. We observed that PfGrp170 exhibits basal ATPase activity and has the capability to suppress the heat induced aggregation of model substrate malate dehydrogenase in a nucleotide independent manner. In addition, using molecular docking and molecular dynamics simulations we show evidence of selective binding to nucleotides and the protein structure is more responsive to ATP binding than ADP. Findings from this study provide the first direct evidence for the independent chaperone function of PfGrp170 and its sensitivity to structural modulation by nucleotides which could be targeted in antimalarial drug development strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.